News

GRM Overseas has announced the launch of its 10X Basmati Rice Suitable for Diabetics. The product will be rolled out across key International and Domestic markets, marking an important step in GRM`s strategy to expand its health-focused product portfolio globally. This new launch addresses the rising demand for healthier dietary choices on account of rising diabetes prevalence, urban lifestyles, and health awareness across markets.

GRM Overseas announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 2 May 2026.

Net profit of GRM Overseas rose 41.36% to Rs 19.14 crore in the quarter ended December 2025 as against Rs 13.54 crore during the previous quarter ended December 2024. Sales rose 30.05% to Rs 482.79 crore in the quarter ended December 2025 as against Rs 371.24 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales482.79371.24 30 OPM %4.443.32 - PBDT26.2619.52 35 PBT25.4618.78 36 NP19.1413.54 41 Powered by Capital Market - Live News

GRM Overseas will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live News

The board of GRM Overseas at its meeting held on 26 December 2025 has approved the allotment of 12,27,04,000 fully paid up bonus equity shares in the ratio 2:1. Post allotment, the paid up equity share capital has increased to Rs. 36,81,12,000/- divided into 18,40,56,000 equity shares of Rs. 2/- each. Powered by Capital Market - Live News